High Vista Strategies LLC Apellis Pharmaceuticals, Inc. Transaction History

High Vista Strategies LLC

$329 Million
Q3 2025

A detailed history of High Vista Strategies LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, High Vista Strategies LLC holds 145,729 shares of APLS stock, worth $2.96 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares

145,729

Previous 86,663 68.16%

Holding current value

$2.96 Million

Previous $1.5 Million 119.8%

% of portfolio

1.0%

Previous 0.62%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$17.42 - $28.65 $1.03 Million - $1.69 Million	59,066 Added 68.16%	145,729 $3.3 Million
Q2 2025 Aug 14, 2025	SELL	$16.36 - $23.0 $360,754 - $507,173	-22,051 Reduced 20.28%	86,663 $1.5 Million
Q4 2024 Feb 14, 2025	BUY	$26.18 - $35.42 $1.9 Million - $2.58 Million	72,739 Added 202.19%	108,714 $3.47 Million
Q3 2024 Nov 14, 2024	BUY	$28.84 - $41.15 $819,315 - $1.17 Million	28,409 Added 375.48%	35,975 $1.04 Million
Q2 2024 Aug 14, 2024	BUY	$38.07 - $59.71 $11,421 - $17,913	300 Added 4.13%	7,566 $290,000
Q1 2024 May 15, 2024	BUY	$55.39 - $72.47 $402,463 - $526,567	7,266 New	7,266 $427,000
Q2 2023 Aug 14, 2023	SELL	$76.68 - $93.31 $680,074 - $827,566	-8,869 Reduced 22.68%	30,242 $2.76 Million
Q4 2022 Feb 14, 2023	SELL	$43.24 - $61.04 $623,996 - $880,868	-14,431 Reduced 26.95%	39,111 $2.02 Million
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $331,268 - $515,553	7,401 Added 16.04%	53,542 $3.66 Million
Q2 2022 Aug 15, 2022	BUY	$35.07 - $59.21 $324,327 - $547,574	9,248 Added 25.07%	46,141 $2.09 Million
Q1 2022 May 16, 2022	BUY	$35.46 - $54.12 $1.31 Million - $2 Million	36,893 New	36,893 $1.88 Million
Q4 2021 Feb 14, 2022	SELL	$30.74 - $49.16 $607,514 - $971,549	-19,763 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$31.4 - $69.84 $620,558 - $1.38 Million	19,763 New	19,763 $651,000

Others Institutions Holding APLS

# of Institutions

330

Shares Held

124M

Call Options Held

4.15M

Put Options Held

769K

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.23B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Account

High Vista Strategies LLC Apellis Pharmaceuticals, Inc. Transaction History